ACCURACY: Phase (P) 2 trial of AL101, a pan-Notch inhibitor, in patients (pts) with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) with Notch activating mutations (Notch(act mut)) Meeting Abstract
| Authors: | Ferrarotto, R.; Ho, A. L.; Wirth, L. J.; Dekel, E.; Walker, R. W.; Vergara-Silva, A. L. |
| Abstract Title: | ACCURACY: Phase (P) 2 trial of AL101, a pan-Notch inhibitor, in patients (pts) with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) with Notch activating mutations (Notch(act mut)) |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 366s |
| Language: | English |
| ACCESSION: | WOS:000487345803416 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.TPS6098 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS6098 -- Source: Wos |
